You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardexpand all lines: report/discussion.tex
+2-2
Original file line number
Diff line number
Diff line change
@@ -66,9 +66,9 @@ \subsection{Exhaustive and time-aware feature extraction}
66
66
This study demonstrated that addition of temporal context significantly improved predictive accuracy (fig.\ref{fig:temporal_integration}).
67
67
The convolution approach (eq.\ref{eq:window}) appeared to provide better results.
68
68
Instead of averaging feature after calculation, it may be advantageous to compute features over epochs of different length in a first place.
69
-
Thus, the accuracy of local of non additive features, such as median, will be improved. In addition to local mean of feature, other variables, such as local
69
+
Thus, the accuracy of local of non additive features, such as median, will be improved. In addition to local mean of feature, other interval variables, such as local
70
70
slope and local variance of each feature may improve
When awake (WAKE), animals tend to have a high muscular activity which translates to high amplitude voltage changes in the \gls{emg}\cite{crisler_sleep-stage_2008}.
21
19
During wakefulness, \gls{eeg} is dominated by relatively low amplitude oscillations of frequencies
22
20
between six and ten hertz often referred to as theta waves.
The third state, \gls{rem} sleep, is characterised by a complete lack of muscular activity (atony) and an \gls{eeg} activity very similar to the awake state.
30
25
\gls{rem} sleep is the least prevalent of all three stages, and represents generally 20\% of all sleeping time.
31
26
The prevalence of these three states as well as their temporal organisation are extremely important observations in sleep research
keywords = {Boosting, Kernel methods, Time series classification},
1368
1368
pages = {171--178},
1369
1369
file = {ScienceDirect Full Text PDF:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/I9EZDS2J/Rodríguez et al. - 2005 - Support vector machines of interval-based features.pdf:application/pdf;ScienceDirect Snapshot:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/4B4QII39/S0950705105000432.html:text/html}
1370
+
}
1371
+
1372
+
@article{pack_novel_2007,
1373
+
title = {Novel method for high-throughput phenotyping of sleep in mice},
abstract = {Assessment of sleep in mice currently requires initial implantation of chronic electrodes for assessment of electroencephalogram ({EEG}) and electromyogram ({EMG}) followed by time to recover from surgery. Hence, it is not ideal for high-throughput screening. To address this deficiency, a method of assessment of sleep and wakefulness in mice has been developed based on assessment of activity/inactivity either by digital video analysis or by breaking infrared beams in the mouse cage. It is based on the algorithm that any episode of continuous inactivity of ≥40 s is predicted to be sleep. The method gives excellent agreement in C57BL/6J male mice with simultaneous assessment of sleep by {EEG}/{EMG} recording. The average agreement over 8,640 10-s epochs in 24 h is 92\% (n = 7 mice) with agreement in individual mice being 88–94\%. Average {EEG}/{EMG} determined sleep per 2-h interval across the day was 59.4 min. The estimated mean difference (bias) per 2-h interval between inactivity-defined sleep and {EEG}/{EMG}-defined sleep was only 1.0 min (95\% confidence interval for mean bias −0.06 to +2.6 min). The standard deviation of differences (precision) was 7.5 min per 2-h interval with 95\% limits of agreement ranging from −13.7 to +15.7 min. Although bias significantly varied by time of day (P = 0.0007), the magnitude of time-of-day differences was not large (average bias during lights on and lights off was +5.0 and −3.0 min per 2-h interval, respectively). This method has applications in chemical mutagenesis and for studies of molecular changes in brain with sleep/wakefulness.},
1380
+
language = {en},
1381
+
number = {2},
1382
+
urldate = {2014-09-08},
1383
+
journal = {Physiological Genomics},
1384
+
author = {Pack, Allan I. and Galante, Raymond J. and Maislin, Greg and Cater, Jacqueline and Metaxas, Dimitris and Lu, Shan and Zhang, Lin and Smith, Randy Von and Kay, Timothy and Lian, Jie and Svenson, Karen and Peters, Luanne L.},
1385
+
month = feb,
1386
+
year = {2007},
1387
+
pmid = {16985007},
1388
+
note = {Assessment of sleep in mice currently requires initial implantation of chronic electrodes for assessment of electroencephalogram ({EEG}) and electromyogram ({EMG}) followed by time to recover from surgery. Hence, it is not ideal for high-throughput screening. To address this deficiency, a method of assessment of sleep and wakefulness in mice has been developed based on assessment of activity/inactivity either by digital video analysis or by breaking infrared beams in the mouse cage. It is based on the algorithm that any episode of continuous inactivity of ≥40 s is predicted to be sleep. The method gives excellent agreement in C57BL/6J male mice with simultaneous assessment of sleep by {EEG}/{EMG} recording. The average agreement over 8,640 10-s epochs in 24 h is 92\% ( n = 7 mice) with agreement in individual mice being 88–94\%. Average {EEG}/{EMG} determined sleep per 2-h interval across the day was 59.4 min. The estimated mean difference (bias) per 2-h interval between inactivity-defined sleep and {EEG}/{EMG}-defined sleep was only 1.0 min (95\% confidence interval for mean bias −0.06 to +2.6 min). The standard deviation of differences (precision) was 7.5 min per 2-h interval with 95\% limits of agreement ranging from −13.7 to +15.7 min. Although bias significantly varied by time of day ( P = 0.0007), the magnitude of time-of-day differences was not large (average bias during lights on and lights off was +5.0 and −3.0 min per 2-h interval, respectively). This method has applications in chemical mutagenesis and for studies of molecular changes in brain with sleep/wakefulness.},
1389
+
pages = {232--238},
1390
+
file = {Full Text PDF:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/XMMFF5TN/Pack et al. - 2007 - Novel method for high-throughput phenotyping of sl.pdf:application/pdf;Snapshot:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/66MD7FI2/232.html:text/html}
1391
+
}
1392
+
1393
+
@article{mieda_orexin_2004,
1394
+
title = {Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice},
1395
+
volume = {101},
1396
+
issn = {0027-8424, 1091-6490},
1397
+
url = {http://www.pnas.org/content/101/13/4649},
1398
+
doi = {10.1073/pnas.0400590101},
1399
+
abstract = {Narcolepsy-cataplexy is a neurological disorder associated with the inability to maintain wakefulness and abnormal intrusions of rapid eye movement sleep-related phenomena into wakefulness such as cataplexy. The vast majority of narcoleptic-cataplectic individuals have low or undetectable levels of orexin (hypocretin) neuropeptides in the cerebrospinal fluid, likely due to specific loss of the hypothalamic orexin-producing neurons. Currently available treatments for narcolepsy are only palliative, symptom-oriented pharmacotherapies. Here, we demonstrate rescue of the narcolepsy-cataplexy phenotype of orexin neuron-ablated mice by genetic and pharmacological means. Ectopic expression of a prepro-orexin transgene in the brain completely prevented cataplectic arrests and other abnormalities of rapid eye movement sleep in the absence of endogenous orexin neurons. Central administration of orexin-A acutely suppressed cataplectic behavioral arrests and increased wakefulness for 3 h. These results indicate that orexin neuron-ablated mice retain the ability to respond to orexin neuropeptides and that a temporally regulated and spatially targeted secretion of orexins is not necessary to prevent narcoleptic symptoms. Orexin receptor agonists would be of potential value for treating human narcolepsy.},
1400
+
language = {en},
1401
+
number = {13},
1402
+
urldate = {2014-09-08},
1403
+
journal = {Proceedings of the National Academy of Sciences of the United States of America},
1404
+
author = {Mieda, Michihiro and Willie, Jon T. and Hara, Junko and Sinton, Christopher M. and Sakurai, Takeshi and Yanagisawa, Masashi},
1405
+
month = mar,
1406
+
year = {2004},
1407
+
pmid = {15070772},
1408
+
pages = {4649--4654},
1409
+
file = {Full Text PDF:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/4Q3NPZ2M/Mieda et al. - 2004 - Orexin peptides prevent cataplexy and improve wake.pdf:application/pdf;Snapshot:/home/quentin/.mozilla/firefox/kkgy4t0w.default/zotero/storage/DGBKJEEK/4649.html:text/html}
0 commit comments